StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Myomo, Inc.
NYSE American:MYO
Sector
Location
Market Cap
USD 73.40 M
Share Price
USD 2.04
Avg Daily Volume
564,261
Change (1 day)
0.49%
Change (1 year)
-28.92%
Change (YTD)
-68.32%
Myomo, Inc. Total Assets for the year ending December 31, 2024: USD 42.24 M
Myomo, Inc. Total Assets is USD 42.24 M for the year ending December 31, 2024, a 189.71% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.
-
Myomo, Inc. Total Assets for the year ending December 31, 2023 was USD 14.58 M, a 43.49% change year over year.
-
Myomo, Inc. Total Assets for the year ending December 31, 2022 was USD 10.16 M, a -49.43% change year over year.
-
Myomo, Inc. Total Assets for the year ending December 31, 2021 was USD 20.10 M, a 36.61% change year over year.
-
Myomo, Inc. Total Assets for the year ending December 31, 2020 was USD 14.71 M, a 122.92% change year over year.
Competitors
PROCEPT BioRobotics Corporation
USD 56.97
PRCT
-0.95
-1.64%
Boston Scientific Corporation
USD 103.83
BSX
-0.49
-0.47%
Siemens Healthineers AG
USD 54.56
SHL.DE
-0.44
-0.81%
Cencora, Inc.
USD 302.50
COR
+6.27
2.12%
Edwards Lifesciences Corporation
USD 76.69
EW
-0.10
-0.13%
GE HealthCare Technologies Inc.
USD 74.61
GEHC
-1.46
-1.92%
DexCom, Inc.
USD 82.94
DXCM
+0.01
0.01%
IQVIA Holdings Inc.
USD 162.45
IQV
-1.79
-1.09%
Natera, Inc.
USD 158.69
NTRA
-3.07
-1.90%
Laboratory Corporation of America Holdings
USD 257.87
LH
-4.02
-1.54%
Baxter International Inc.
USD 29.69
BAX
-1.32
-4.26%
Somnigroup International Inc
USD 71.93
SGI
+0.06
0.08%
Hologic, Inc.
USD 64.37
HOLX
-0.41
-0.63%
Torrent Pharmaceuticals Limited
USD 38.81
TORNTPHARM.NS
-0.21
-0.53%
Fisher & Paykel Healthcare Corporation Limited
USD 21.95
FPH.NZ
+0.37
1.70%
ICON Public Limited Company
USD 147.59
ICLR
-2.51
-1.67%
Zydus Lifesciences Limited
USD 11.50
ZYDUSLIFE.NS
-0.12
-1.05%
Regencell Bioscience Holdings Limited
USD 18.43
RGC
-4.56
-19.84%
Ascendis Pharma A/S
USD 175.98
ASND
+1.80
1.03%
Exact Sciences Corporation
USD 52.48
EXAS
-0.88
-1.65%
Key Data
| Date | Total Assets | Accounts Payable | Short-Term Debt | Long-Term Debt |
|---|
Competitors
PROCEPT BioRobotics Corporation
USD 56.97
PRCT
-0.95
-1.64%
Boston Scientific Corporation
USD 103.83
BSX
-0.49
-0.47%
Siemens Healthineers AG
USD 54.56
SHL.DE
-0.44
-0.81%
Cencora, Inc.
USD 302.50
COR
+6.27
2.12%
Edwards Lifesciences Corporation
USD 76.69
EW
-0.10
-0.13%
GE HealthCare Technologies Inc.
USD 74.61
GEHC
-1.46
-1.92%
DexCom, Inc.
USD 82.94
DXCM
+0.01
0.01%
IQVIA Holdings Inc.
USD 162.45
IQV
-1.79
-1.09%
Natera, Inc.
USD 158.69
NTRA
-3.07
-1.90%
Laboratory Corporation of America Holdings
USD 257.87
LH
-4.02
-1.54%
Baxter International Inc.
USD 29.69
BAX
-1.32
-4.26%
Somnigroup International Inc
USD 71.93
SGI
+0.06
0.08%
Hologic, Inc.
USD 64.37
HOLX
-0.41
-0.63%
Torrent Pharmaceuticals Limited
USD 38.81
TORNTPHARM.NS
-0.21
-0.53%
Fisher & Paykel Healthcare Corporation Limited
USD 21.95
FPH.NZ
+0.37
1.70%
ICON Public Limited Company
USD 147.59
ICLR
-2.51
-1.67%
Zydus Lifesciences Limited
USD 11.50
ZYDUSLIFE.NS
-0.12
-1.05%
Regencell Bioscience Holdings Limited
USD 18.43
RGC
-4.56
-19.84%
Ascendis Pharma A/S
USD 175.98
ASND
+1.80
1.03%
Exact Sciences Corporation
USD 52.48
EXAS
-0.88
-1.65%